Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. - Wikidata - awgldk - TriplyDB

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

http://www.wikidata.org/entity/Q33987611

about

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda Animal models for Ebola and Marburg virus infections Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates Effective post-exposure treatment of Ebola infection Wave-like spread of Ebola Zaire Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein Current ebola vaccines Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses The 2014–2015 Ebola outbreak in West Africa: Hands On A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb Emerging targets and novel approaches to Ebola virus prophylaxis and treatment Ebola haemorrhagic fever Ebolavirus vaccines for humans and apes Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Clinical development of Ebola vaccines Ebola virus vaccines: an overview of current approaches Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections Ebolavirus glycoprotein structure and mechanism of entry Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Global research trends of World Health Organization's top eight emerging pathogens.Ebola hemorrhagic Fever and the current state of vaccine development Progress towards the treatment of Ebola haemorrhagic fever.Ebola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus Ebola virus - from neglected threat to global emergency state.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

P2860

Q21090030-C68C7FA8-0CC0-46DC-A78E-FFA441C7A48B Q21090120-9D01585F-1087-43FC-9ACE-27524750FA41 Q21090519-E590E8EA-0CBC-407E-ACE6-B93574CB9114 Q21131118-3CBD418A-AFA0-4EC6-AE83-B0652431E2CF Q21131585-DE931B64-C4AE-4431-8C4E-FFFA9CE540BE Q21131616-41E137E3-89CA-42C6-A93A-2478A82D58DF Q21146083-66CFD1E6-9933-4D5B-878A-EDA7E1696CBB Q21245136-BE3283D7-67F9-4E02-B0AE-4E113BEA85A1 Q21534720-B04D2E0C-3D4B-4D26-BBE5-E32AA207CDF1 Q21559476-D1732FCF-6276-4DC2-B4DD-65CD53277847 Q21562420-626DDA13-BBAC-489A-8110-533EAEEC7C6E Q24049114-22B6B077-7EB5-4656-B2B1-10351DAFD922 Q24289279-83567F0A-B95D-4DE5-8C45-199F4154EAF3 Q24289281-631D37BE-A2BB-41FC-ADE7-BCFCF80EA11A Q24289295-16E7720D-C6F7-437F-A83B-448C62FA035E Q24594601-7DDD5192-ACE3-42A5-BC67-88DFD1EB2A32 Q24597625-C7CB7447-3B4D-49C8-B1D2-8C1E5AEB7F49 Q24629338-63063A10-259A-424D-8F57-E853390675DB Q24631696-0E91AAE9-6677-4786-85C7-FF132ED8F6CE Q25256700-DAFF9F56-10F4-4159-A6A0-8ED219D8137D Q26775792-E8583FB6-5127-4AA0-B381-A71D6D5AD955 Q26999232-1ACAD069-8F70-448E-9665-3B3B3B1CBC6C Q27011190-162FFFEE-07A6-46FF-A621-0280CF564EE0 Q27310373-B5B00880-CB13-4D6D-BA35-68A2F482F871 Q27485491-DEB6040B-0498-4ECC-802A-03A4DBC60EBB Q27490991-9168D672-1066-4B27-B0AE-68500F8DF81C Q27651112-2067B847-75A9-49D1-8C15-002F07796F91 Q28051937-13BF968E-066B-47F1-9B24-B62E28D235E2 Q28485505-7CFE6DF6-DB8C-437F-ABDF-88F6E3B80E64 Q28768041-C4FE3496-94E4-48BB-B394-0B16BDB173A9 Q29994671-FB5D07C6-8B20-4C8E-816E-58AE293094C1 Q30151375-EA0FE4D8-DB6C-4317-911C-4DFD85737452 Q30205198-24D4C641-3E01-4582-8A50-083776BEDBA9 Q30230272-D838AA26-783D-43A9-A51E-AF831A662776 Q30234637-CF369905-464C-430B-B26A-217035F89E94 Q30235073-EEF2472B-73C6-4FFB-9816-17ECDC06FFB1 Q30245153-4655E339-8C67-4951-B236-C0CB009908E8 Q30361939-0CCCC276-27BA-400D-9753-9C044FB96109 Q30375073-D271DC03-6892-4566-B539-073F0B3CF891 Q30378994-B2117F23-784D-4E5F-8366-E5CFE58CC751

P2860

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

http://www.wikidata.org/entity/Q33987611

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@ast

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@en

type

label

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@ast

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@en

prefLabel

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@ast

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@en

P1433

Q33987611-01D2AAEB-7AD5-4318-9048-D455B31CA653

P1476

Q33987611-543A58C4-55FD-45F0-A028-899B302BA200

P2093

Q33987611-5616A3FB-6DA0-43C0-83EA-F3ABB6C679D3

Q33987611-5B3F7DCF-3FC0-4AF5-84D2-7F5F95E17965

Q33987611-73F0933F-36AF-47FC-AFF0-22E1E7C9CA39

Q33987611-BD94F324-3A73-44B1-AAAB-AD813A0527B1

Q33987611-C36C4738-FA5F-4BAE-A9F7-AA949498B65A

Q33987611-CA9CD2D0-E08F-4477-808C-CF8F7ACADC00

P2860

Q33987611-1107706D-5730-4907-9D9F-252B8631E546

Q33987611-15E3608D-A111-4C61-8663-06B3CBD3BAC3

Q33987611-1ED8FC3D-EA40-415B-8BB2-1459EFC535DF

Q33987611-2A67F926-C648-40E3-8588-C52ADFC4C5DE

Q33987611-409E30C2-51C9-4115-BB50-DCC80B6A6417

Q33987611-5BC1F03E-3ABD-4B61-99EB-F55524D9DCB2

Q33987611-5BD51080-F552-4428-8331-135B0A4184C2

Q33987611-5CC88A76-0056-42C2-A3AF-2896843D925A

Q33987611-6B45FE19-2A73-4B61-AB1C-0450E8069500

Q33987611-6DB27D30-709A-4D93-8275-27697A8B2D02

P2888

Q33987611-106C47BA-139A-413A-BA4E-822B63DB57C1

P304

Q33987611-1253CAC8-E4C0-4ADD-A2C8-60ED7BADC96B

P31

Q33987611-DFD3A967-74D1-4F63-9250-43D2892DF0D2

P356

Q33987611-8B07D2B9-9337-4A55-AC91-6CF9815263B6

P407

Q33987611-351BBBD6-A789-41C8-9E64-E28B06B6128A

P433

Q33987611-3199EAFF-BA5D-4FBE-98FC-FCD388D36C0B

P478

Q33987611-EFAFC873-C8AE-4DD5-A30B-C85EA5305306

P50

Q33987611-14FF330D-3355-4636-AEC0-AAA99EB005D0

Q33987611-23C591BB-3500-4658-942F-8822640101FD

Q33987611-531BCC4B-B862-4D12-A727-B9B8CF074F72

Q33987611-798FB00C-9F48-4491-B62A-9AE00821DD7B

Q33987611-B825CD23-B937-4CE2-AE00-67C932899675

Q33987611-C3871C31-EE1D-4ECA-B7F9-5021A6625A87

Q33987611-E0DDDF39-34EA-429C-9E73-CA724B18FC7A

Q33987611-E97E80C7-A874-49CD-B111-52F73E51D40E

P577

Q33987611-D1966474-A1F8-4084-B31B-AE867CCEA2C0

P5875

Q33987611-89F7E193-6F4D-45A3-A885-A19B45A1EE6C

P6179

Q33987611-AD76B233-53B3-4583-9707-759282E4A555

P698

Q33987611-42BCAE0A-E845-4AAA-8D89-957383700D9D

P921

Q33987611-3D279F14-8F40-4075-9237-D47CF0CA6DE2

Q33987611-442FD23E-EA80-46FF-A80C-A915706C47A3

Q33987611-66043D3A-AF03-43FF-8BD7-76EA86844DE4

Q33987611-9DBFECFF-0B3E-4F7C-A821-7DBE4D6B535D

P356

P1433

Nature Medicine

P1476

Live attenuated recombinant va ...... nst Ebola and Marburg viruses.

@en

P2093

Elizabeth A Fritz

http://www.w3.org/2001/XMLSchema#string

Joan B Geisbert

http://www.w3.org/2001/XMLSchema#string

Kathleen M Daddario

http://www.w3.org/2001/XMLSchema#string

Lisa Fernando

http://www.w3.org/2001/XMLSchema#string

Nancy J Sullivan

http://www.w3.org/2001/XMLSchema#string

Steven M Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a preventive vaccine for Ebola virus infection in primates

Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

Marburg-virus disease in Kenya.

Hemorrhagic fever viruses as biological weapons: medical and public health management.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Ebola virus: from discovery to vaccine.

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

Towards a vaccine against Ebola virus.

P2888

P304

786-790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1258

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Dieter Klenk

Peter B. Jahrling

Viktor Volchkov

Thomas W Geisbert

P577

2005-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7803807

http://www.w3.org/2001/XMLSchema#string

P6179

1037827335

http://www.w3.org/2001/XMLSchema#string

P698

15937495

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

Vaccine against Ebola